IDEMIA Appoints Astrid Warren as Chief People Officer
IDEMIA Group announced today the appointment of Astrid Warren as Chief People Officer and a member of the Executive Committee, effective May 18th
Astrid comes with over 20 years of experience in leading HR in global technology organizations. Reporting directly to IDEMIA Group President and CEO, she will oversee the People strategy and agenda for IDEMIA Group.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210519005441/en/
“I am very pleased to welcome Astrid Warren to IDEMIA’s executive committee. Astrid brings exceptional experience across all facets of human resources strategy and development on a global scale. Her deep experience in leading Human Resources in the tech industry - where she has spent her entire career - combined with a proven track record of building high performing, diverse teams who deliver business results across regions and cultures, will be a great asset to our Group”, said Pierre Barrial, IDEMIA Group President & CEO.
“I am honored to be joining IDEMIA, a Group with great ambitions and expertise for the future, and a company whose purpose – to make the world a safer place – is aligned with my personal values. My job in Human Resources has always been driven by my passion for helping people grow and develop their skills and I look forward to meeting and working with the teams at IDEMIA to help them expand their capability to deliver business results”, said Astrid Warren, new Chief People Officer at IDEMIA.
NOTE TO EDITORS – Astrid Warren’s biography
Based in Switzerland, Astrid is a South African national human resources executive with over 20 years of experience mostly in the high-tech sector as well as in global environments.
She was previously Senior Vice-President Human Resources for SITA, the world's leading specialist in air transport communications and information technology and a company recognized by Forbes as 2020 Best Employers. Before that, she spent 13 years within Microsoft, where she held a number of senior HR leadership roles, such as head of HR for Microsoft Middle East & Africa, in Turkey.
Prior to joining Microsoft in 1997, Warren was Responsible for the Human Resources function at Altron and Human Resources Manager at Standard Bank of South Africa.
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.
For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CELLTRION-HEALTHCARE12.6.2021 17:47:13 CEST | Press release
Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large B-cell lymphoma at the EHA 2021 Virtual Congress
JANSSEN12.6.2021 09:03:12 CEST | Press release
Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX®▼ (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
JANSSEN12.6.2021 09:02:12 CEST | Press release
New Phase 3 Study Results Show IMBRUVICA® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia
GALDERMA11.6.2021 11:55:08 CEST | Press release
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe
SLOTS-CAPITAL11.6.2021 11:24:04 CEST | Pressemeddelelse
Slots Capital er nu tilgængelig for flere spillere end nogensinde før
SLOTS-CAPITAL11.6.2021 11:23:04 CEST | Press release
Slots Capital Available to More Players Than Ever Before
SECURE-COMMUNITIES-FORUM11.6.2021 10:17:07 CEST | Press release
Secure Communities Forum: Behavioural Insights Can Assist Governments in the Post-Pandemic World
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom